Revance Therapeutics, Inc.

TN · United States · Reporting entity ID 100001448152

Total reported 2019–2025

$5.99M

#648 of 2,960 reporting companies — 0% of all reported industry payments

$5.99M in general payments across 45,148 records.

How it breaks down

General payments $5,990,627

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.